Cite

HARVARD Citation

    Disselhorst, M. et al. (2022). Immune cells in mesothelioma microenvironment simplistic marker of response to nivolumab plus ipilimumab?. Lung cancer. pp. 49-52. [Online]. 
  
Back to record